View Older Stories

Jan 30, 2026 06:47AM Praxis Precision Medicines Inc. (PRAX) PT Raised to $1,245 at H.C. Wainwright

Jan 28, 2026 08:52AM Praxis Precision Medicines Inc. (PRAX) PT Raised to $1,200 at Piper Sandler on 'Major Upside Potential'

Jan 23, 2026 07:00AM Piper Sandler: 'Praxis Precision Medicines Inc. (PRAX) One of Our 2026 Best-Ideas'

Jan 13, 2026 04:30PM Praxis Precision Medicines hires epilepsy expert Dr. Orrin Devinsky as head of clinical strategy

Jan 12, 2026 08:04AM Praxis plans two drug applications by mid-February, raises $1.5 billion

Jan 8, 2026 04:45PM Praxis appoints two board directors and promotes two executives

Jan 6, 2026 04:42PM After-hours movers: Strategy, Mobileye, Ventyx Bioscience, Praxis

Jan 5, 2026 07:08AM Needham Names MindMed (MNMD) New Top Pick for 2026, Adds to Conviction List

Jan 2, 2026 08:56AM TD Cowen Reiterates Buy Rating on Praxis Precision Medicines Inc. (PRAX)

Dec 31, 2025 07:16AM TD Cowen: 'We view yesterday's announcement as highly positive for PRAX'

Dec 30, 2025 08:22AM Truist Reiterates 'High Conviction' Buy Rating on Praxis Precision Medicines Inc. (PRAX)

Dec 30, 2025 06:37AM H.C. Wainwright Reiterates Buy Rating on Praxis Precision Medicines Inc. (PRAX)

Dec 29, 2025 09:23AM Guggenheim on Praxis Precision Medicines (PRAX): one of our Top Picks for 2026

Dec 29, 2025 08:51AM Jefferies Reiterates Buy Rating on Praxis Precision Medicines Inc. (PRAX)

Dec 29, 2025 08:01AM FDA grants breakthrough therapy designation to Praxis drug for essential tremor

Dec 29, 2025 06:07AM Praxis Precision Medicines Inc. (PRAX) PT Raised to $843 (from $507) at BTIG

Dec 22, 2025 07:06AM Piper Sandler Highlights Top Picks in the Biopharma 2026 Preview Note

Dec 15, 2025 04:35AM Praxis Precision Medicines Inc. (PRAX) PT Raised to $750 (from $250) at Oppenheimer

Dec 11, 2025 08:02AM Praxis plans to file NDA for relutrigine in rare epilepsies by early 2026

Dec 9, 2025 04:01PM Praxis gets FDA agreement to simplify elsunersen trial design

Dec 8, 2025 09:18AM Praxis Precision Medicines Inc. (PRAX) PT Raised to $353 at TD Cowen

Dec 8, 2025 07:32AM Piper Sandler on Biotechnology: 'What Commercial Names to Own in 2026?'

Dec 8, 2025 07:10AM Praxis Precision Medicines Inc. (PRAX) PT Raised to $315 at Needham

Dec 8, 2025 06:30AM Praxis Precision Medicines Inc. (PRAX) PT Raised to $760 at Guggenheim, 'remains one of our top picks for 2025'

Dec 8, 2025 06:26AM Praxis Precision Medicines Inc. (PRAX) PT Raised to $500 at Truist Securities

Dec 8, 2025 06:17AM Praxis Precision Medicines (PRAX) call put ratio 1 call to 6 puts

Dec 5, 2025 07:20AM Piper Sandler on Praxis Precision Medicines (PRAX): 'Two Major Wins Set the Stage for Multiple Potential Approvals in 2026'

Dec 5, 2025 07:08AM Praxis Precision Medicines Inc. (PRAX) PT Raised to $304 at Needham

Dec 5, 2025 06:44AM Praxis Precision Medicines Inc. (PRAX) PT Raised to $340 at H.C. Wainwright

Dec 4, 2025 04:38PM After-hours movers: HPE, Ulta Beauty, SoFi, Rubrik and more

Dec 4, 2025 04:12PM Praxis stops EMBOLD study early after relutrigine shows efficacy

Dec 4, 2025 04:01PM Praxis receives FDA alignment on ulixacaltamide NDA submission plans

Nov 24, 2025 09:06AM TD Cowen on Praxis Precision Medicines Inc. (PRAX): 'Sensitivity Analyses Robust & Supportive Of Topline'

Nov 20, 2025 10:49AM Praxis Precision Medicines (PRAX) Mentioned as Short at Culper Research

Nov 6, 2025 01:11PM Praxis Precision Medicines Inc. (PRAX) PT Raised to $540 at Guggenheim

Nov 5, 2025 08:05AM Praxis Precision Medicines (PRAX) Tops Q3 EPS by 11c

Oct 24, 2025 08:29AM Piper Sandler: 'Biotech Has a Heartbeat: 17 Stocks to Own Through YE25'

Oct 16, 2025 12:52PM Praxis Precision Medicines Inc. (PRAX) PT Raised to $250 at Oppenheimer

Oct 16, 2025 12:31PM Praxis Precision Medicines Inc. (PRAX) PT Raised to $360 at Truist Securities

Oct 16, 2025 12:28PM Praxis Precision Medicines Inc. (PRAX) PT Raised to $275 at Baird

Oct 16, 2025 12:25PM Praxis Precision Medicines Inc. (PRAX) PT Raised to $251 at TD Cowen as Ph3 ET Ulixa Studies Meet Primary

Oct 16, 2025 10:34AM Praxis Precision Medicines Inc. (PRAX) PT Raised to $350 at Guggenheim

Oct 2, 2025 08:08AM Piper Sandler Sees a 'Lucrative Buying Opportunity Ahead' for Praxis Precision Medicines (PRAX)

Sep 17, 2025 04:26PM Jones Trading Starts Praxis Precision Medicines Inc. (PRAX) at Buy

Sep 17, 2025 07:30AM Piper Sandler Reiterates Overweight Rating on Praxis Precision Medicines Inc. (PRAX)

Aug 11, 2025 08:25AM Piper Sandler Reiterates OW Rating on Praxis Precision Medicines Inc. (PRAX)

Aug 5, 2025 07:37AM Truist Reiterates Buy Rating on Praxis Precision Medicines Inc. (PRAX)

Aug 5, 2025 06:43AM Praxis Precision Medicines Inc. (PRAX) PT Raised to $115 at H.C. Wainwright

Aug 4, 2025 02:10PM TD Cowen Reiterates Buy Rating on Praxis Precision Medicines Inc. (PRAX)

Aug 4, 2025 01:24PM Praxis Precision Medicines Inc. (PRAX) PT Raised to $33 at Wedbush

View Older Stories